Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
Thymosin Beta-4 Heritage: Parent compound is endogenous and well-characterized Clinical Trials: RegeneRx trials showed generally favorable safety in ophthalmic and cardiac applications Cancer Concerns: Theoretical concerns about cell migration and tumor potential
Claims surrounding BPC-157 benefits derive exclusively from preclinical animal studies, which regulatory bodies do not accept as sufficient evidence for human therapeutic approval
What this means in practice: BPC-157 does not act on only one tissue type
International journal of physiology, pathophysiology and pharmacology, 10(3), 132138 Santra, M., Zhang, Z
Third party testing verification adds an extra layer of quality assurance beyond our internal quality control
Expression Atlas: gene and protein expression across multiple studies and organisms
US$ 22.95
US$ 29.83
US$ 21.74
US$ 24.85
US$ 23.72
